Anti-Mycobacterium avium Antibody (18103)

Cell extract of M. avium obtained from the National Veterinary Services Laboratories, Ames, Iowa.

This monoclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.2 - 7.4 with no carrier protein or preservatives added.

Liquid

Antibodies are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

Upon initial thawing, appropriately aliquot and store at -80°C. For long-term storage, keep at -80°C. Avoid repeated freeze-thaw cycles.

Next Day 2-8°C

This antibody recognize M. avium. It do not cross-react with Mycobacterium tuberculosis, Mycobacterium phlei, Corynebacterium bovis, or Mycoplasma bovis.

Mycobacteria are small, slow-growing, aerobic bacilli. They are distinguished by a complex, lipid- rich cell envelope responsible for their characterization as acid-fast (i.e. resistant to decolorization by acid after staining with carbolfuchsin) and their relative resistance to Gram stain. The most common mycobacterial infection is tuberculosis; others include leprosy and various diseases caused by Mycobacterium avium complex. The term Mycobacterium avium complex (MAC) refers to two species: M. avium and M. intracellulare. Because these species are difficult to differentiate, they are also collectively referred to as Mycobacterium avium-intracellulare (MAI). MAC primarily affects individuals who are immune compromised (e.g., from AIDS, hairy cell leukemia, immunosuppressive chemotherapy).